You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
The Breast: Comprehensive Management of Benign and Malignant Diseases, 4th Edition, by Kirby I. Bland, MD, and Edward M. Copeland, III, MD, is a surgical reference that offers the most comprehensive, up-to-date resource on the diagnosis and management of, and rehabilitation following, surgery for benign and malignant diseases of the breast. With its multidisciplinary approach, sweeping updates, new contributors, and authoritative guidance, you’ll have exactly what you need to inspire patient confidence and provide the best possible outcomes. Features multidisciplinary advice from experts in surgery, radiation and medical oncology, pathology, molecular biology, pharmacokinetics, and genetic...
This book is devoted to the controversial topic of dose intensity for breast cancer. Over the past 15 years, there have been dozens of phase I and II clinical trials, motivated by preclinical evidence suggesting a potential therapeutic role for doses of chemotherapy sufficiently myelotoxic as to require the reinfusion of hematopoietic stem cells. Unfortunately, there is a paucity of data from prospective, randomized clinical trials to inform us adequately as to the role of this strategic approach to breast cancer treatment, whether for early stage or advanced disease. The objective of this special edition is to provide a timely and thorough overview of where we are in our understanding of the potential for and limitations of high dose chemotherapy for breast cancer, where we are headed, and perhaps, how we will get there.
Current Topics in Breast Cancer Survivorship is an important collection of essays about the health and wellbeing of breast cancer survivors. The audience for the book includes graduate students, health professionals and researchers from many different disciplines, including epidemiology, behavioral science, medicine, oncology, nursing, and health disparities. This book will likely be of interest to health professionals and researchers from various disciplines and members of non-profit organizations, government agencies, and health advocacy organizations. The book is organized into six key sections. The first section provides information about comorbid conditions such as cardiovascular diseas...
This textbook provides current information on best practice in multidisciplinary cancer care. Divided into six sections, the contributors look at the aetiology of cancer, patient care, population health and thethe management of specific types of disease. Written and edited by internationally recognised leaders in the field, the new edition of the Oxford Textbook of Oncology has been fully revised and updated, taking into consideration the advancements in each of the major therapeutic areas, and representing the multidisciplinary management of cancer. Structured in six sections, the book provides an accessible scientific basis to the key topics of oncology, examining how cancer cells grow and...
Completely revised and updated, and now in full color throughout, the Fourth Edition of this definitive reference is a must for all clinicians who treat breast diseases. Leading experts summarize the current knowledge of breast diseases, including their clinical features, management, underlying biologies, and epidemiologies. In addition to complete coverage of malignant breast diseases, benign diseases are discussed in relation to subsequent breast cancer development. The book reviews all major clinical trials and summarizes the information they provide on early detection and management of breast cancer. Close attention is also given to the increasing importance of molecular biology and gene...
Reproductive medicine is a growing field with new technology emerging faster than we can assess consumer’s perceptions of –the number of cancer survivors are growing and there is a great need to attend to their quality of life-this book addresses the needs of males and females, identifies effective communication strategies and proactive measures for health care professionals and researchers to use as well as identifying gaps in the literature where more research is needed.
The efficacy of adjuvant chemotherapy was first demonstrated in the early 1970's. Prolonged follow-up of these trials confirms the lasting improvement in overall survival with the administration of adjuvant chemotherapy. The early meta-analysis offers the practicing physician a good sense of the broad trends in adjuvant therapy (both chemotherapy and hormonal therapy), but falls short during periods of rapid changes in available agents or approaches. This volume deals with different views on the early overview. One view highlights therapeutic advances that have not yet been incorporated. Another view places the overview in context, contrasting the consensus recommendations with actual delive...
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.